| 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging … J Calais, F Ceci, M Eiber, TA Hope, MS Hofman, C Rischpler, ... The Lancet Oncology 20 (9), 1286-1294, 2019 | 374 | 2019 |
| Anti-3-[18F]FACBC Positron Emission Tomography-Computerized Tomography and 111In-Capromab Pendetide Single Photon Emission Computerized … DM Schuster, PT Nieh, AB Jani, R Amzat, FDB Bowman, RK Halkar, ... The Journal of urology 191 (5), 1446-1453, 2014 | 206 | 2014 |
| Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In–Capromab Pendetide SPECT/CT DM Schuster, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, PJ Rossi, ... Radiology 259 (3), 852-861, 2011 | 174 | 2011 |
| Recurrent prostate cancer detection with anti-3-[18F]FACBC PET/CT: comparison with CT OA Odewole, FI Tade, PT Nieh, B Savir-Baruch, AB Jani, VA Master, ... European journal of nuclear medicine and molecular imaging 43, 1773-1783, 2016 | 156 | 2016 |
| Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease DM Schuster, C Nanni, S Fanti, S Oka, H Okudaira, Y Inoue, J Sörensen, ... Journal of Nuclear Medicine 55 (12), 1986-1992, 2014 | 152 | 2014 |
| Characterization of primary prostate carcinoma by anti-1-amino-2-[18F]-fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) uptake DM Schuster, PA Taleghani, PT Nieh, VA Master, R Amzat, ... American journal of nuclear medicine and molecular imaging 3 (1), 85, 2013 | 102 | 2013 |
| Appropriate use criteria for prostate-specific membrane antigen PET imaging H Jadvar, J Calais, S Fanti, F Feng, KL Greene, JL Gulley, M Hofman, ... Journal of Nuclear Medicine 63 (1), 59-68, 2022 | 75 | 2022 |
| Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of breast cancer: an exploratory study FI Tade, MA Cohen, TM Styblo, OA Odewole, AI Holbrook, MS Newell, ... Journal of Nuclear Medicine 57 (9), 1357-1363, 2016 | 62 | 2016 |
| ACR–ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer B Savir-Baruch, KP Banks, JE McConathy, OP Molchanova-Cook, ... Clinical nuclear medicine 43 (12), 909-917, 2018 | 48 | 2018 |
| Imaging of prostate cancer using fluciclovine B Savir-Baruch, L Zanoni, DM Schuster PET clinics 12 (2), 145-157, 2017 | 48 | 2017 |
| [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging—version 1.0 C Nanni, L Zanoni, T Bach-Gansmo, H Minn, F Willoch, TV Bogsrud, ... European journal of nuclear medicine and molecular imaging 47, 579-591, 2020 | 43 | 2020 |
| Pilot Study of the Utility of the Synthetic PET Amino-Acid Radiotracer Anti-1-Amino-3-[18F]Fluorocyclobutane-1-Carboxylic Acid for the Noninvasive Imaging of … R Amzat, P Taleghani, DL Miller, JJ Beitler, LM Bellamy, JA Nye, W Yu, ... Molecular imaging and biology 15, 633-643, 2013 | 36 | 2013 |
| Imaging of prostate cancer using fluciclovine B Savir-Baruch, L Zanoni, DM Schuster Urologic Clinics 45 (3), 489-502, 2018 | 32 | 2018 |
| Fluorine-18-labeled fluciclovine PET/CT in clinical practice: factors affecting the rate of detection of recurrent prostate cancer B Savir-Baruch, P Lovrec, AA Solanki, WH Adams, PM Yonover, G Gupta, ... American Journal of Roentgenology 213 (4), 851-858, 2019 | 26 | 2019 |
| Pilot Evaluation of Anti-1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in Recurrent Prostate Carcinoma B Savir-Baruch, DM Schuster, N Jarkas, VA Master, PT Nieh, RK Halkar, ... Molecular imaging and biology 13, 1272-1277, 2011 | 24 | 2011 |
| ACR–ACNM practice parameter for the performance of dopamine transporter (DAT) Single photon emission computed tomography (SPECT) imaging for movement disorders RM Subramaniam, KA Frey, CH Hunt, GA Mercier Jr, LB Solnes, ... Clinical nuclear medicine 42 (11), 847-852, 2017 | 22 | 2017 |
| Diagnostic performance and safety of positron emission tomography with 18F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate-to very-high-risk prostate … DS Surasi, M Eiber, T Maurer, MA Preston, BT Helfand, D Josephson, ... European urology 84 (4), 361-370, 2023 | 21 | 2023 |
| SNMMI procedure standard/EANM guideline for gated equilibrium radionuclide angiography MB Farrell, JR Galt, P Georgoulias, S Malhotra, R Pagnanelli, C Rischpler, ... Journal of Nuclear Medicine Technology 48 (2), 126-135, 2020 | 17 | 2020 |
| Unusual presentations of metastatic prostate carcinoma as detected by anti-3 F-18 FACBC PET/CT R Amzat, P Taleghani, B Savir-Baruch, PT Nieh, VA Master, RK Halkar, ... Clinical nuclear medicine 36 (9), 800-802, 2011 | 17 | 2011 |
| Reproducibility and Reliability of Anti-3-[18F]FACBC Uptake Measurements in Background Structures and Malignant Lesions on Follow-Up PET-CT in Prostate … OA Odewole, OA Oyenuga, F Tade, B Savir-Baruch, PT Nieh, V Master, ... Molecular Imaging and Biology 17, 277-283, 2015 | 16 | 2015 |
